Sign In
Buy CNTA
$39.85
-0.0500 (-0.125%)
At Close: Jun 03, 2026
Campbell & CO Investment Adviser LLC Acquires New Position in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA
03:53am, Tuesday, 18'th Nov 2025
Campbell and CO Investment Adviser LLC bought a new position in shares of Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ: CNTA) during the second quarter, according to its most recent filing with
Centessa Stock Has Surged 77% Over the Past Year — But a Top Biotech Fund Is Still Buying
11:15am, Monday, 17'th Nov 2025
California-based TCG Crossover Management increased its stake in Centessa Pharmaceuticals by 245,664 shares in the third quarter for an estimated $38.1 million. The transaction value equaled about 0.2
Why Centessa Pharmaceuticals Stock Crushed the Market Today
06:27pm, Wednesday, 12'th Nov 2025
It's gearing up to take in a flood of fresh capital. This is being effected in a secondary issue of its ADSes.
Centessa Pharmaceuticals Announces Pricing of $250,000,000 Public Offering of American Depositary Shares
08:40pm, Tuesday, 11'th Nov 2025
BOSTON and LONDON, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company, today announced the pricing of an underwritten public offerin
Centessa Pharmaceuticals Announces Proposed Public Offering of American Depositary Shares
04:00pm, Tuesday, 11'th Nov 2025
BOSTON and LONDON, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company, today announced that it has commenced an underwritten public
Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences
08:00am, Friday, 07'th Nov 2025
BOSTON and LONDON, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop transformational medicines
46,665 Shares in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA Purchased by Y Intercept Hong Kong Ltd
03:40am, Thursday, 06'th Nov 2025
Y Intercept Hong Kong Ltd purchased a new position in shares of Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ: CNTA) in the undefined quarter, according to the company in its most recent 13F fili
BOSTON and LONDON, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company, today reported financial results for the third quarter ended
Centessa Pharmaceuticals to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
07:00am, Wednesday, 03'rd Sep 2025
BOSTON and LONDON, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop transformational medicines
Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Second Quarter of 2025
07:00am, Tuesday, 12'th Aug 2025
Advancing a broad, potential best-in-class orexin receptor 2 (OX2R) agonist franchise, with key data readouts expected this year
Tokyo, Japan and Cambridge, UK, 4 July 2025 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) today announces that it will receive US$4.8 million in milestone payments from Cente
Centessa Pharmaceuticals (CNTA) Upgraded to Buy: What Does It Mean for the Stock?
01:01pm, Monday, 16'th Jun 2025
Centessa Pharmaceuticals (CNTA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
BOSTON and LONDON, June 16, 2025 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company, today announced that the U.S. Food and Drug Administration (F
Wall Street Analysts Think Centessa Pharmaceuticals (CNTA) Could Surge 138.77%: Read This Before Placing a Bet
10:55am, Wednesday, 04'th Jun 2025
The consensus price target hints at a 138.8% upside potential for Centessa Pharmaceuticals (CNTA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in
Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences
08:00am, Monday, 19'th May 2025
BOSTON and LONDON, May 19, 2025 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop transformational medicines f
